Cefepime, is effective against both gram positive and gram negative pathogens including the pseudomonas and is life saving for patients suffering from serious infections treated by oncologists, physicians and surgeons.

Citadel Aurobindo Biotech Ltd., (Aurobindo's joint venture with Citadel) is launching the first injectable formulation in India with the brand name, Cefeprime. Cefeprime is available in 1 gram and 500 mg vials.

The pioneering research efforts are enabling Aurobindo to be a front-runner in the Cephalosporin category. Aurobindo is amongst the top Cephalosporin players in the world with a comprehensive product portfolio and state-of-the-art mega facilities for both sterile and non-sterile API & formulations.